FDA hopes new payment models would spark antibiotic drug development

The Food and Drug administration is considering a new payment model aimed at encouraging drugmakers to develop new antibiotics.

Read the full post at Modern Healthcare Breaking News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive